CN100508989C - Medicinal powder for treating beriberi - Google Patents
Medicinal powder for treating beriberi Download PDFInfo
- Publication number
- CN100508989C CN100508989C CNB2006101283056A CN200610128305A CN100508989C CN 100508989 C CN100508989 C CN 100508989C CN B2006101283056 A CNB2006101283056 A CN B2006101283056A CN 200610128305 A CN200610128305 A CN 200610128305A CN 100508989 C CN100508989 C CN 100508989C
- Authority
- CN
- China
- Prior art keywords
- vitamin
- foot
- medicated powder
- metronidazole
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicinal powder to treat beriberi, which is characterized by the following: blending metronidazole, chlorpheniramine, boracic acid and vitamin B1; adding drug powder together under 20 deg.c; reserving in the bottle.
Description
One, technical field
The present invention relates to a kind of medicine, the beriberic medicated powder of particularly a kind of treatment.
Two, background technology
Beriberi claims tinea pedis, claims the fungal infection polyneuritis again, is China and foreign countries' medical circle a great problems, be difficult to eradicate, the beriberi pad of promoting burns foot in the market, and the medicine function singleness, weak effect, controlling of having is smelly, and what have controls foot pruritus, what have controls foot bubble, have to control foot mashed, what also have controls swelling of the feet, the foot pruritus medicine of Tui Guanging is and controls table and do not effect a permanent cure in the market, weak effect, and the cycle is long, recurrent is fast, and not the same Comprehensive Treatment beriberi is promoted.And beriberi is a common frdquently encountered disease, and people's orthobiosis, work, study and productive labor brought great influence and inconvenience, and therefore, effective treatment of beriberi is concerned about by people.
Three, summary of the invention
At above-mentioned situation, the present invention's purpose just provides the beriberic medicated powder of a kind of treatment, can effectively solve comprehensive efficient treatment problem fast to beriberi, and the technical scheme of its solution is that this medicated powder is by metronidazole, chlorphenamine, boric acid and vitamin B
1Mix forming, is a kind of compositions, during manufacturing, only needs four kinds of medicated powder are mixed to stir with blender at temperature below 20 ℃ to be stored in standby getting final product in the bottle, prescription is simple and easy to produce, and cost is low, the curative effect height, drug safety is the beriberic efficient good medicine of treatment, and clinical meaning is huge.
Four, the specific embodiment
Below in conjunction with practical situation the specific embodiment of the present invention is elaborated.
Provided by technique scheme, in force, the present invention is by metronidazole 3-5g, chlorphenamine 1.5-2.5g, boric acid 8-12g and vitamin B
13-5g forms, and wherein the metronidazole quality purity is 80-95%, and the chlorphenamine quality purity is 85-97%, vitamin B
1Quality purity is 90-98%, and the boric acid quality purity is 98-99.5%.Said medicine all adopts powder, or is ground into fine powder by tablet and all can.
The present invention is preferably by metronidazole 4g, chlorphenamine 2g, boric acid 10g and vitamin B
14g forms.By said components than the medicated powder that can be made into any amount.
During production, only needing with blender medicated powder to be stirred under the temperature below 20 ℃ get final product in the container that places sealing, and the time spent seals not In Shade.
The present invention can be effective to treat vitamin B1 deficiencys such as sweaty foot is too much, foot odor, foot pruritus, large and small blister, swelling of the feet, foot is mashed, foot suppurates, stream yellow fluid, congestion and swelling pain.
In said medicine, wherein metronidazole is the commercially available prod, has the effect of antiinflammatory, pain relieving, sterilization; Vitamin B
1Has vitamin B for want of
1The disease treatment that causes; Chlorphenamine is the commercially available prod, is a kind of antiallergic medicine commonly used, has the toxic and side effects that prevents that inappropriate medication from causing, the effect that suppresses antibacterial is arranged; Boric acid and contact skin have greasy sliding effect, also have the effect of corrosion-proof and sterilization simultaneously, effective combination of said medicine, function is supported each other, just in time reach the purpose of treatment vitamin B1 deficiency, clinical data also proves the therapeutic effect that it is unique fully, and interrelated data is as follows:
One, selects the standard of case
All have that foot odor, foot pruritus, foot are perspired and mashed with foot, the stream yellow fluid, and bulla, vesicle suppurate and the foot shedding, and red pain person all can be used as the standard of selecting case.
Two, diagnostic criteria
All symptoms with above-mentioned (), diagnosable is the vitamin B1 deficiency patient.
Three, therapeutic scheme
Before the sleep, foot is cleaned with warm water, wear footwear the next morning before, the medicine branch is put in two footwear, every interior 3-4g spills evenly, a small amount of medicated powder of reuse spills in the affected part, puts on footwear then, every morning each once, can take effect for 4-5 time, generally medication is 7 days, gets final product.
Four, efficacy assessment standard
1, cure: symptom is eliminated, and 3 years with interior no longer recurrence;
2, effective: symptom is eliminated substantially, and no significant discomfort sensation or symptom are obviously improved or the partial symptoms elimination in 3 years, the alleviation of particularly aching, itch;
3, invalid: disease does not have any improvement, and the trend that increases the weight of is arranged.
After the healing,, preferably after the drug withdrawal, irregularly spill a small amount of medicated powder in foot again, often prevent for preventing recurrence.
Five, statistical disposition
Nearly 3 years, clinical warp was added up 455 vitamin B1 deficiency patients, wherein man, woman half and half, and age 6-75 year, statistical result such as following table:
Above-mentioned showing, no matter medicine men and women, old and young of the present invention, effect is all outstanding especially, really is that As the medicine took effect, the symptoms lessened, and curative effect is that other any treatment vitamin B1 deficiency medicines can't be compared up to more than 99.3%.
Six, conclusion
Medicine of the present invention has unique curative effect, and its pharmacological research proves that vitamin B1 deficiency is a Vitamin B1 deficiency, and have sweaty foot and pathogenic bacteria (fungus) to soak a kind of foot disease due to the corruption, and the organic assembling of medicine of the present invention is supported mutually, medicated powder dissolves in footwear, is absorbed by foot skin, and pore increases, absorb the drug the scarce vitamin of subsidy, and disinfection, go inflammation, go the antiperspirant deodorization, relieving itching and eliminating swelling goes bubble to remove pus, synthetic somatoblast, make the skin smooth delicacy, thereby reach the purpose of treatment vitamin B1 deficiency, prescription is simple, science, pharmacology is clear, meets clinical practice fully, has outstanding clinical meaning, therapeutic effect good, do not expect that medicated powder of the present invention was the ideal medicine of treatment vitamin B1 deficiency, economy and social value are huge.
Claims (4)
1, the beriberic medicated powder of a kind of treatment is characterized in that, is by metronidazole 3-5g, chlorphenamine 1.5-2.5g, boric acid 8-12g and vitamin B
13-5g forms.
2, the beriberic medicated powder of a kind of treatment according to claim 1 is characterized in that, by metronidazole 4g, chlorphenamine 2g, boric acid 10g and vitamin B
14g forms.
3, the beriberic medicated powder of a kind of treatment according to claim 1 is characterized in that the metronidazole quality purity is 80-95%, and the chlorphenamine quality purity is 85-97%, vitamin B
1Quality purity is 90-98%, and the boric acid quality purity is 98-99.5%.
4, the beriberic medicated powder of a kind of treatment according to claim 1 is characterized in that said metronidazole, chlorphenamine, boric acid and vitamin B
1Be the composition that under the temperature below 20 ℃, stirs, place in the container of sealing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101283056A CN100508989C (en) | 2006-11-30 | 2006-11-30 | Medicinal powder for treating beriberi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101283056A CN100508989C (en) | 2006-11-30 | 2006-11-30 | Medicinal powder for treating beriberi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1969880A CN1969880A (en) | 2007-05-30 |
| CN100508989C true CN100508989C (en) | 2009-07-08 |
Family
ID=38111028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101283056A Expired - Fee Related CN100508989C (en) | 2006-11-30 | 2006-11-30 | Medicinal powder for treating beriberi |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100508989C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810720A (en) * | 2010-04-08 | 2010-08-25 | 徐金刚 | Skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation and using method thereof to beriberi skin disease |
-
2006
- 2006-11-30 CN CNB2006101283056A patent/CN100508989C/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 脚气糊的研制与临床疗效观察. 王周武等.贵州医药，第11卷第2期. 1987 |
| 脚气糊的研制与临床疗效观察. 王周武等.贵州医药，第11卷第2期. 1987 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1969880A (en) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100512869C (en) | Chinese medicine for treating tinea pedis by soaking feet | |
| CN103070961B (en) | Chinese medicinal anti-bacteria health care foot-massage solution and preparation method thereof | |
| CN102114207A (en) | Pill for treating hyperlipidemia and preparation method thereof | |
| CN107467315A (en) | A kind of tea for reducing hypertension and fat and preparation method thereof | |
| CN109316550A (en) | A kind of cleaning is antibacterial to use care agent | |
| CN100508989C (en) | Medicinal powder for treating beriberi | |
| US8591960B2 (en) | Composition and method for treating bedsores, cuts and burns | |
| CN101134094B (en) | Liniment for treating skin pruritus, eczema and scaly tetter | |
| CN101628096B (en) | Traditional Chinese medicine composition for treating infantile diarrhea | |
| CN100400049C (en) | Medicinal powder for treating beriberi and preparation method thereof | |
| CN106943444A (en) | One kind treats dermopathic pharmaceutical composition and its production and use | |
| CN101011433A (en) | Medicinal liquor for treating skin disease and trauma | |
| CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN112057492A (en) | Pure natural foot bath effervescent pill and preparation process thereof | |
| CN1061865C (en) | External-use Chinese medicine preparation for treating skin ulcer | |
| JPH04128219A (en) | Plaster for treating skin ulcer | |
| NL2031436B1 (en) | Hemorrhoid and fistula mixture | |
| CN102935218A (en) | Traditional Chinese medicine composition for treating decubitus in clinical care | |
| CN106390062A (en) | Nerve soothing and sleeping promoting essential oil powder, and preparation method and application thereof | |
| CN102552609A (en) | Foot bath Chinese medicinal composition for treating bullous-type beriberi | |
| CN108295178B (en) | Traditional Chinese medicine composition and traditional Chinese medicine ointment for treating refractory wound and preparation method thereof | |
| CN106377654A (en) | Impregnation medicine for treating rhagadia manus and pedalis | |
| CN1895518A (en) | Medicine for treating beriberi | |
| CN1084627C (en) | Traditional Chinese medicinal plaster for treating psoriasis | |
| CN1072500C (en) | Medical capsules for treating arthritides and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090708 Termination date: 20101130 |